The cell surface antigen chondroitin sulfate proteoglycan 4 (CSPG4) is expressed on 90% of melanoma tumors and metastases, as well as on sarcomas, astrocytomas, gliomas, neuroblastomas, and leukemia.32, 33, 34, 35. The gene discussed is CSPG4; the disease is neuroblastoma.